|
Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches |
02/28/2025 - 8:00am to 9:00am EST |
|
Chronic Lymphocytic Leukemia |
03/26/2021 - 8:00am to 9:00am EDT |
|
Chronic Lymphocytic Leukemia |
05/20/2022 - 8:00am to 9:00am EDT |
|
Chronic Myelogenous Leukemia |
03/17/2023 - 8:00am to 9:00am EDT |
|
Claudin 18.2 a New Target for Precision Care of Gastric and Gastroesophageal Cancers: A Case Discussion |
03/07/2025 - 8:00am to 9:00am EST |
|
CLL and Autoimmune Hemolytic Anemia |
09/30/2022 - 8:00am to 9:00am EDT |
|
Coagulopathy Associated with COVID |
02/12/2021 - 8:00am to 9:00am EST |
|
Cold Agglutinin Disease: Clinical Challenges and Therapeutic Strategies |
04/04/2025 - 8:00am to 9:00am EDT |
|
Collaborations: The Vital Underpinning of Translational Science |
07/22/2022 - 8:00am to 9:00am EDT |
|
Community Practice Perspectives: Exploring Treatment Intensification with CDK 4/6i in Adjuvant HR+, HER2-, High-Risk Early Breast Cancer |
09/05/2025 - 8:00am to 9:00am EDT |